Corestem Overview
- Founded
-
2003
- Status
-
Public
- Employees
-
392
- Stock Symbol
-
166480
- Investments
-
1
- Share Price
-
$6.26
- (As of Thursday Closing)
Corestem General Information
Description
Corestemchemon Inc formerly Corestem Inc is a South Korea based company biopharmaceutical company. It is primarily engaged in the business activity of developing and producing stem cell therapy for the treatment of incurable diseases. The company's NEURONATA-R inj., a stem cell therapy, is for Lou Gehrig's disease which is a rare incurable disease. In addition to the therapy of Lou Gehrig's disease, it also has a pipeline of therapies for various diseases such as lupus, multiple system atrophy, and osteoarthritis.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Pharmaceuticals
Stock Exchange
KRX
Primary Office
- Number 1008, Number 902, Number 401 (the holy one, SK Techno Building)
- 133-710 gu, holy days 55
- Seoul, 04779
- South Korea
+82 00-000-0000
Corestem Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.26 | $6.11 | $5.36 - $11.28 | $157M | 25.1M | 75.1K | -$0.26 |
Corestem Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 153,026 | 142,465 | 235,874 | 291,120 |
| Revenue | 36,732 | 35,827 | 26,401 | 22,324 |
| EBITDA | 5,962 | 9,887 | 3,290 | (10,647) |
| Net Income | (4,766) | (2,056) | (6,110) | (19,638) |
| Total Assets | 71,531 | 62,248 | 114,627 | 130,964 |
| Total Debt | 17,752 | 14,598 | 23,226 | 18,479 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Corestem Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Corestem Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Kyung Suk Kim | Co-Chief Executive Officer | ||
| Gyeong Suk Kim | Executive |
Corestem Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Corestem Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Corestem Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 | 01-Dec-2022 | 000000000 | 000.00 | Laboratory Services (Healthcare) |